Description

Mounjaro (15mg pen) is a cutting-edge treatment for type 2 diabetes, combining the benefits of glucose control and weight management. Tirzepatide is the active ingredient. It works by activating both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This means it not only helps your body release insulin when blood sugar levels are high but also slows digestion and reduces appetite, aiding in weight loss.

The 15mg pen is designed for once-weekly subcutaneous injection, providing a consistent and hassle-free way to manage your condition. Its user-friendly design ensures accurate dosing, making it ideal for those who prefer a straightforward administration process. Mounjaro is typically prescribed alongside a healthy diet and exercise plan to maximise its effectiveness.

Ingredients

• Active ingredient: Tirzepatide (15mg per dose)
• Inactive ingredients: Sodium chloride, sodium phosphate, water for injections, and hydrochloric acid (for pH adjustment).

Instructions for Use

• Wash your hands thoroughly before handling the pen.
• Check the pen to ensure it contains the correct dosage and is not damaged.
• Attach a new needle to the pen and remove the outer and inner needle caps.
• Perform a safety test by turning the dose selector to the flow check symbol and pressing the injection button until a drop appears at the needle tip.
• Select the prescribed dose (15mg) by turning the dose selector.
• Inject into your abdomen, thigh, or upper arm, holding the pen in place for 5 seconds after pressing the button.
• Dispose of the needle safely after each use.

Potential Side Effects

• Common side effects: nausea, diarrhoea, decreased appetite, vomiting, constipation, and indigestion.
• Less common side effects: Hypoglycaemia (low blood sugar), dizziness, and fatigue.
• Rare but serious side effects: Pancreatitis, severe allergic reactions, and kidney problems.
• Consult your doctor immediately if you experience severe or persistent side effects.